NASDAQ: SLN

Silence Therapeutics PLC Stock Forecast, Predictions & Price Target

The consensus among 3 Wall Street analysts covering (NASDAQ: SLN) stock is to Strong Buy SLN stock.

Out of 3 analysts, 2 (66.67%) are recommending SLN as a Strong Buy, 1 (33.33%) are recommending SLN as a Buy, 0 (0%) are recommending SLN as a Hold, 0 (0%) are recommending SLN as a Sell, and 0 (0%) are recommending SLN as a Strong Sell.

If you're new to stock investing, here's how to buy Silence Therapeutics stock.

(NASDAQ: SLN) Silence Therapeutics's forecast annual revenue growth rate of 2.7% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.77%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 7.57%.

Silence Therapeutics's revenue in 2023 is $35,051,250.On average, 4 Wall Street analysts forecast SLN's revenue for 2023 to be $3,846,304,521, with the lowest SLN revenue forecast at $2,442,006,037, and the highest SLN revenue forecast at $5,522,065,909. On average, 3 Wall Street analysts forecast SLN's revenue for 2024 to be $3,159,294,557, with the lowest SLN revenue forecast at $2,882,843,232, and the highest SLN revenue forecast at $3,654,308,322.

In 2025, SLN is forecast to generate $4,812,086,006 in revenue, with the lowest revenue forecast at $1,773,789,659 and the highest revenue forecast at $9,779,625,128.

According to 3 Wall Street analysts that have issued a 1 year SLN price target, the average SLN price target is $40.33, with the highest SLN stock price forecast at $75.00 and the lowest SLN stock price forecast at $20.00.

On average, Wall Street analysts predict that Silence Therapeutics's share price could reach $40.33 by Nov 17, 2024. The average Silence Therapeutics stock price prediction forecasts a potential upside of 176.63% from the current SLN share price of $14.58.

(NASDAQ: SLN) forecast ROE is N/A, which is considered weak.